Chidamide Monotherapy for Intermediate-to-High-Risk Myelodysplastic Syndromes
Chidamide Monotherapy for Intermediate-to-High-Risk Myelodysplastic Syndromes
Not yet recruiting · NCT07616336 · Registry updated 2026-06-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Chidamide Monotherapy for Intermediate-to-High-Risk Myelodysplastic Syndromes | Hemic and Lymphatic Diseases, bone marrow disorder, hematologic disorder, myelodysplastic syndrome | Not yet recruiting | Phase 2 | 2026-06-01 | NCT07616336 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Zhongshan Hospital (Xiamen), Fudan University | 8 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Zhongshan Hospital (Xiamen), Fudan University | Xiamen | China | 1 |